News ReleasesRSS
- Apr 18, 2019 Nemolizumab Shows Positive Results in Maruho’s Phase 3 Study in Atopic Dermatitis
- Apr 17, 2019 F. Hoffmann-La Roche Announces First Quarter Sales 2019
- Apr 08, 2019 Conclusion of Exclusive Licensing and Capital Tie-up Agreements Concerning “Telomelysin (OBP-301),” Oncolytic Viral Immunotherapy
- Apr 01, 2019 Business Transfer of ULCERLMIN® for the Treatment of Gastritis/Peptic Ulcer from Chugai Pharmaceutical to Fuji Chemical Industries
- Mar 29, 2019 Chugai Files an Application for Expanded Use of Genomic Mutation Analysis Program “FoundationOne CDx Cancer Genomic Profile” as a Companion Diagnostic of Lynparza
What's NewRSS
- Mar 28, 2019 Updated Message from the CEO
- Mar 28, 2019 Posted Annual Report 2018
- Mar 28, 2019 Notice of Resolutions of the 108th Annual General Meeting
- Mar 28, 2019 Notice Regarding Year-End Dividend for the Fiscal Year ending December, 2018
- Mar 28, 2019 Updated Directors & Officers
